Oral rivaroxaban versus enoxaparin with vitamin K antagonist for the treatment of symptomatic venous thromboembolism in patients with cancer (EINSTEIN-DVT and EINSTEIN-PE): a pooled subgroup analysis of two randomised controlled trials - Prins, M H; Lensing, A WA; Brighton, T A (Lancet Haematology, 2014)
, et al.